Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma

被引：0
|
作者：
DeLiberty, Jonathan M.
Stalnecker, Clint A.
Drizyte-Miller, Kristina
Schechter, Elyse G.
Pieper, Noah L.
Yang, Runying
Der, Channing J.
Cox, Adrienne D.
Bryant, Kirsten L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4851
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4851
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Roach, Mallory K.
    Pieper, Noah L.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (02)
  • [2] Dual inhibition of PIKfyve and KRAS/MAPK as a potential for therapeutic strategy for pancreatic ductal adenocarcinoma
    Wisniewski, Jasmine P.
    Cheng, Caleb
    Jackson, Bailey
    Korkaya, Ahmet
    Peters, Sydney
    Qiao, Yuanyuan
    Lyssiotis, Costas A.
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Concurrent inhibition of the RAS ERK-MAPK pathway and PIKfyve as a therapeutic strategy for pancreatic cancer
    DeLiberty, Jonathan M.
    Roach, Mallory K.
    Stalnecker, Clint A.
    Robb, Ryan
    Schechter, Elyse G.
    Pieper, Noah L.
    Yang, Runying
    Bang, Scott
    Taylor, Khalilah E.
    Drizyte-Miller, Kristina
    Morris, John P.
    Der, Channing J.
    Cox, Adrienne D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (17)
  • [4] Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
    Raufi, Alexander G.
    Liguori, Nicholas R.
    Carlsen, Lindsey
    Parker, Cassandra
    Hernandez Borrero, Liz
    Zhang, Shengliang
    Tian, Xiaobing
    Louie, Anna
    Zhou, Lanlan
    Seyhan, Attila A.
    El-Deiry, Wafik S.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Vertical inhibition of the autophagy pathway enhances sensitization to RAS MAPK pathway inhibition in pancreatic ductal adenocarcinoma
    Roach, Mallory K.
    DeLiberty, Jonathan M.
    Schechter, Elyse G.
    Yang, Runying
    Pieper, Noah L.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (17)
  • [6] Inhibition of p38 enhances ERK inhibitor efficacy in pancreatic ductal adenocarcinoma
    Ryan, Meagan B.
    Bryant, Kirsten L.
    Hayes, Tikvah K.
    Kher, Swapnil
    Wood, Kris C.
    Samatar, Ahmed A.
    Cox, Adrienne D.
    Der, Channing J.
    CANCER RESEARCH, 2016, 76
  • [7] Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma
    Haney, Staci L.
    Varney, Michelle L.
    Chhonker, Yashpal S.
    Shin, Simon
    Mehla, Kamiya
    Crawford, Ayrianne J.
    Smith, Heather Jensen
    Smith, Lynette M.
    Murry, Daryl J.
    Hollingsworth, Michael A.
    Holstein, Sarah A.
    ONCOGENE, 2019, 38 (26) : 5308 - 5320
  • [8] Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma
    Staci L. Haney
    Michelle L. Varney
    Yashpal S. Chhonker
    Simon Shin
    Kamiya Mehla
    Ayrianne J. Crawford
    Heather Jensen Smith
    Lynette M. Smith
    Daryl J. Murry
    Michael A. Hollingsworth
    Sarah A. Holstein
    Oncogene, 2019, 38 : 5308 - 5320
  • [9] MAPK inhibition remodels antigen presentation in pancreatic ductal adenocarcinoma
    Creech, Amanda L.
    Le, Thuc M.
    Abt, Evan R.
    Capri, Joseph R.
    Donahue, Timothy R.
    Radu, Caius G.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Susceptibility to autophagy inhibition is enhanced by dual IGF1R and MAPK/ERK inhibition in pancreatic cancer
    Stalnecker, Clint A.
    Coleman, Michael F.
    Bryant, Kirsten L.
    AUTOPHAGY, 2022, 18 (07) : 1737 - 1739
12345